Association between GFR Estimated by Multiple Methods at Dialysis Commencement and Patient Survival
|
|
- Wesley Henderson
- 5 years ago
- Views:
Transcription
1 Article Association between GFR Estimated by Multiple Methods at Dialysis Commencement and Patient Survival Muh Geot Wong,* Carol A. Pollock,* Bruce A. Cooper,* Pauline Branley, John F. Collins, Jonathan C. Craig, Joan Kesselhut,* Grant Luxton, Andrew Pilmore, David C. Harris, and David W. Johnson** Summary Background and objectives The Initiating Dialysis Early and Late study showed that planned early or late initiation of dialysis, based on the Cockcroft and Gault estimation of GFR, was associated with identical clinical outcomes. This study examined the association of all-cause mortality with estimated GFR at dialysis commencement, which was determined using multiple formulas. Design, setting, participants, & measurements Initiating Dialysis Early and Late trial participants were stratified into tertiles according to the estimated GFR measured by Cockcroft and Gault, Modification of Diet in Renal Disease, or Chronic Kidney Disease-Epidemiology Collaboration formula at dialysis commencement. Patient survival was determined using multivariable Cox proportional hazards model regression. Results Only Initiating Dialysis Early and Late trial participants who commenced on dialysis were included in this study (n=768). A total of 275 patients died during the study. After adjustment for age, sex, racial origin, body mass index, diabetes, and cardiovascular disease, no significant differences in survival were observed between estimated GFR tertiles determined by Cockcroft and Gault (lowest tertile adjusted hazard ratio, 1.11; 95% confidence interval, 0.82 to 1.49; middle tertile hazard ratio, 1.29; 95% confidence interval, 0.96 to 1.74; highest tertile reference), Modification of Diet in Renal Disease (lowest tertile hazard ratio, 0.88; 95% confidence interval, 0.63 to 1.24; middle tertile hazard ratio, 1.20; 95% confidence interval, 0.90 to 1.61; highest tertile reference), and Chronic Kidney Disease-Epidemiology Collaboration equations (lowest tertile hazard ratio, 0.93; 95% confidence interval, 0.67 to 1.27; middle tertile hazard ratio, 1.15; 95% confidence interval, 0.86 to 1.54; highest tertile reference). Conclusion Estimated GFR at dialysis commencement was not significantly associated with patient survival, regardless of the formula used. However, a clinically important association cannot be excluded, because observed confidence intervals were wide. Clin J Am Soc Nephrol 9: , doi: /CJN Introduction Early observational cohort studies in the 1980s and 1990s suggested that commencing dialysis at a higher level of GFR was associated with improved morbidity and mortality (1 9). These studies led to promulgation of the so-called healthy start dialysis concept, where dialysis was instigated before the development of uremic signs and symptoms (10). Conversely, a number of more recently published observational studies, including a meta-analysis (11), has shown that dialysis initiation at higher estimated GFR (egfr) levels is paradoxically associated with an increased risk of mortality compared with initiation at lower levels (12 22). These results may have been limited by selection, indication, survivor, and misclassification biases. Moreover, a study by the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD) Group found that the Modification of Diet in Renal Disease (MDRD) method of estimation of GFR was influenced by muscle mass to a greater extent than GFR estimated by creatinine clearance (21). Specifically, MDRD egfr at dialysis commencement was inversely associated with muscle mass and survival, whereas mean urinary urea and creatinine clearances were not significantly associated with either muscle mass or survival (21). In 2010, the Initiating Dialysis Early and Late (IDEAL) randomized controlled trial involving 828 patients with ESRD showed that planned early initiation of dialysis at egfr values between 10 and 14 ml/min per 1.73 m 2 based on the Cockcroft and Gault (CG) equation did not confer either a survival or quality of life benefit (23,24) compared with late dialysis commencement (GFR,7 ml/min per 1.73 m 2 or when traditional clinical indicators of uremia supervened). The aim of this preplanned post hoc analysis of the IDEAL trial was to further explore the relationship between egfr at dialysis commencement using three different equations to estimate GFR and subsequent survival. *Department of Renal Medicine, Royal North Shore Hospital, Sydney Medical School, University of Sydney, Sydney, Australia; Monash Medical Centre and Eastern Health Renal Units, Melbourne, Australia; Department of Renal Medicine, Auckland City Hospital, Auckland, New Zealand; Department of Nephrology, Children s Hospital at Westmead, Sydney School of Public Health, University of Sydney, Sydney, Australia; Prince of Wales Clinical School, Faculty of Medicine, University of New South Wales, Sydney, Australia; Centre for Transplantation and Renal Research, Westmead Millennium Institute, University of Sydney, Sydney, Australia; and **Centre for Kidney Disease Research, University of Queensland at Princess Alexandra Hospital, Brisbane, Australia Correspondence: Prof. David W. Johnson, Department of Nephrology, Level 2, ARTS Building, Princess Alexandra Hospital, Ipswich Road, Woolloongabba, Brisbane, QLD 4102, Australia. david_johnson@health. qld.gov.au Vol 9 January, 2014 Copyright 2014 by the American Society of Nephrology 135
2 136 Clinical Journal of the American Society of Nephrology Materials and Methods The IDEAL study design, methodology, and primary results have been described previously (23). The IDEAL trial (Australian and New Zealand Clinical Trials Registry number ) was conducted during the period before the abbreviated MDRD equation widely replaced the CG formula in estimation of GFR. This prespecified post hoc analysis used an as-treated analysis to study the association between the egfr determined by different formulas at the start of dialysis on the IDEAL participants survival. This study included participants who commenced on dialysis from 2000 to 2009, with a median follow-up period of 4.4 years. The study protocol was approved by ethics committees at all participating centers in adherence to the Declaration of Helsinki. All patients provided written informed consent before trial participation. Participants The IDEAL trial included adult patients with stage 5 CKD and a CG egfr value (25) corrected for body surface area (BSA) (26) between 10 and 15 ml/min per 1.73 m 2. Participants from 32 centers in Australia and New Zealand were randomized 1:1 to either commence dialysis at a GFR of ml/min per 1.73 m 2 or continue routine medical care and commence dialysis at a GFR of 5 7 ml/min per 1.73 m 2. The IDEAL trial participants who commenced dialysis during the study were divided into tertiles according to the CG GFR at dialysis commencement. Separate sensitivity analyses were also conducted, in which the GFR at dialysis commencement was alternatively estimated by either the MDRD equation or the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation (27). Sensitivity analyses were also performed using egfr uncorrected for BSA (i.e., by multiplying BSA-corrected GFR by actual BSA divided by 1.73) (26) and analyses by sex. Study Outcomes The primary outcome measure was all-cause mortality. The secondary outcomes are broadly classified as cardiovascular (CV) death and non-cv mortality. Statistical Analyses Results were expressed as frequencies (percentages) for categorical variables, mean 6 SD for continuous normally distributed variables, and median (range) for continuous non-normally distributed variables. Group comparisons were performed by chi-squared test, ANOVA, or Kruskal Wallis test as appropriate. For the primary outcome of allcause mortality, survival estimates and curves were generated using the Kaplan Meier method. The agreement between two egfr formulas was shown by Bland and Altman plots. Survival time was defined as the period from dialysis commencement until death with censoring for transplantation, loss to follow-up, or end of study. A Cox proportional hazards model analysis was used to investigate the association of tertiles of egfr at dialysis commencement for all-cause, CV, and non-cv mortality. Covariates used in the multivariable analyses were age, sex, racial origin, body mass index, presence or absence of diabetes mellitus, and presence or absence of CV disease (defined as presence of at least one of congestive heart failure, ischemic heart disease, peripheral vascular disease, and prior cerebrovascular event). Statistical analyses were performed using SAS version 9.3 (SAS Institute Inc., Cary, NC) and R version (The R Foundation for Statistical Computing). P values less than 0.05 were considered statistically significant. Results Patient Characteristics In total, 768 of 828 IDEAL (93%) participants in the IDEAL trial commenced dialysis during the study period (early start group, n=382; late start group, n=386). One patient from the early start group had no GFR recorded at the commencement of dialysis and was excluded from analysis. Patients were divided into tertiles according to CG egfr at dialysis commencement (i.e.,,9.5 ml/min per 1.73 m 2 [n=248], ml/min per 1.73 m 2 [n=256], and $12.0 ml/min per 1.73 m 2 [n=264]). Based on the CG equation, women were more likely to commence dialysis with a higher egfr. However, the three groups had similar comorbidities at the start of dialysis (Table 1). When egfr at dialysis commencement was determined by the MDRD formula, the tertile cut points were,6.5 ml/ min per 1.73 m 2 (n=255), ml/min per 1.73 m 2 (n=268), and $9.0 ml/min per 1.73 m 2 (n=245). When the CKD-EPI equation was used for GFR estimation, the tertile cut points were,6.0 ml/min per 1.73 m 2 (n=271), ml/min per 1.73 m 2 (n=238), and $8.0 ml/min per 1.73 m 2 (n=259). When these equations were used to estimate GFR, the patients who commenced on dialysis in the highest egfr tertile were older, had a lower body mass index, were more likely to be Caucasian, and were more likely to have ischemic heart disease as a comorbidity. Patients with diabetes mellitus were equally distributed across the tertiles (Table 1). Patients who commenced renal replacement therapy with a higher GFR estimated by the MDRD formula were more likely to commence on peritoneal dialysis than hemodialysis (P,0.05), with a similar trend that did not reach statistical significance when the CKD-EPI formula was used. In a subanalysis, measured GFR using mean urinary urea and creatinine clearances was obtained from 301 participants with a 24-hour urine collection at the point of dialysis commencement. The tertile cut points were,5.9 ml/min (n=99), ml/min (n=99), and $8.2 ml/min (n=103). The baseline characteristics when using this method of GFR measurement are listed in Supplemental Table 1. The baseline characteristics that were similar across all three formulas included hemoglobin, serum albumin, C-reactive protein, calcium, and medications, including angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, and statins. Agreement between egfr Formulas The CG estimation of GFR was a mean of 2.8 ml/min per 1.73 m 2 greater than the GFR estimated by MDRD (limits of agreement= ml/min per 1.73 m 2 ). The CG estimation of GFR was a mean of 3.6 ml/min per 1.73 m 2 greater than the GFR estimated by CKD-EPI (limits of agreement= ml/min per 1.73 m 2 ). The closest
3 Clin J Am Soc Nephrol 9: , January, 2014 egfr and Dialysis Survival, Wong et al. 137 Table 1. Baseline characteristics of the Initiating Dialysis Early and Late trial participants divided in tertiles of estimated GFR at initiation using the Cockcroft and Gault, Modification of Diet in Renal Disease, and Chronic Kidney Disease-Epidemiology Collaboration formulas Characteristics CG (ml/min per 1.73 m 2 ) MDRD (ml/min per 1.73 m 2 ) CKD-EPI (ml/min per 1.73 m 2 ), $12 P Value, $9 P Value, $8 P Value N Randomized group, n (%) Early 57 (23.0) 138 (53.9) 187 (70.8) 80 (31.4) 137 (51.1) 165 (67.4) 84 (31.0) 124 (52.1) 174 (67.2) Late 191 (77.0) 118 (46.1) 77 (29.2) 175 (68.6) 131 (48.9) 80 (32.7) 187 (69.0) 114 (47.9) 85 (32.8) Women, n (%) 68 (27.4) 97 (37.9) 100 (37.9) (39.6) 88 (32.8) 76 (31.0) (37.3) 75 (31.5) 89 (34.4) 0.39 Age (yr) a 60.1 (11.7) 59.3 (12.6) 59.5 (12.7) (12.0) 58.2 (11.7) 65.7 (10.8), (12.0) 59.4 (11.7) 63.3 (12.3),0.001 Duration first 56.2 (71.6) 74.2 (100.7) 66.9 (91.6) (75.0) 70.0 (95.5) 67.6 (95.4) (75.2) 69.3 (92.4) 70.8 (99.0) 0.21 seen by nephrologist (mo) a Race, n (%) Caucasian 169 (68.2) 178 (69.5) 199 (75.4) (63.5) 196 (73.1) 188 (76.7), (63.1) 176 (74.0) 199 (76.8),0.01 Non- Caucasian 79 (31.8) 78 (30.5) 65 (24.6) 93 (36.5) 72 (26.9) 57 (23.3) 100 (36.9) 62 (26.0) 60 (23.2) Comorbidities, n (%) Diabetes 109 (44.0) 110 (43.0) 112 (42.4) (47.1) 113 (42.2) 98 (40.0) (48.0) 100 (42.0) 101 (39.0) 0.10 Congestive 12 (4.8) 16 (6.3) 15 (5.9) (5.5) 10 (3.7) 19 (7.8) (5.5) 10 (4.2) 18 (6.9) 0.41 cardiac failure Peripheral vascular disease Ischemic heart disease 47 (19.0) 43 (16.8) 47 (17.8) (17.3) 48 (17.9) 45 (18.4) (18.1) 39 (16.4) 49 (18.9) (27.4) 68 (26.6) 78 (29.6) (20.8) 76 (28.4) 85 (34.7), (22.1) 70 (29.4) 84 (32.4),0.05 Planned dialysis modality, n (%) Hemodialysis 97 (39.1) 123 (48.1) 119 (45.1) (49.0) 121 (45.1) 93 (38.0) (48.0) 110 (46.2) 99 (38.2) 0.06 Peritoneal 151 (60.9) 133 (52.0) 145 (54.9) 130 (51.0) 147 (54.9) 152 (62.0) 141 (52.0) 128 (53.8) 160 (61.8) dialysis Clinical parameters a Body mass index 28.2 (5.4) 29.7 (6.2) 29.2 (6.4) (6.8) 29.4 (5.7) 26.5 (4.6), (6.7) 29.5 (5.7) 26.5 (4.6),0.001 Systolic BP 143 (20) 145 (21) 141 (21) (20) 143 (21) 143 (22) (19) 143 (21) 143 (22) 0.99 Diastolic BP 79 (11) 80 (11) 78 (12) (11) 79 (11) 78 (12), (10) 79 (12) 78 (12) 0.23 CG, Cockcroft and Gault; MDRD, Modification of Diet in Renal Disease; CKD-EPI, Chronic Kidney Disease-Epidemiology Collaboration. a Mean (SD).
4 138 Clinical Journal of the American Society of Nephrology agreement was observed between the egfr values determined by the MDRD and CKD-EPI formulas, with the difference being 0.8 ml/min per 1.73 m 2 (limits of agreement= ml/min per 1.73 m 2 ). Greater differences were observed at higher levels of egfr (Figure 1). Patient Survival and egfr Grouped in Tertiles A total of 275 (35.8%) patients who commenced dialysis died during the 9-year study period, with a median followup period of 4.4 years. Overall mortality was comparable among the three tertiles when divided using the CG egfr at dialysis commencement (hazard ratio [HR], 1.02; 95% confidence interval [95% CI], 0.76 to 1.37; P=0.38; lowest egfr tertile versus highest egfr tertile) (Figure 2A). When egfr at dialysis initiation was calculated alternatively, using the MDRD formula, the group that had the lowest egfr had the lowest mortality (HR, 0.56; 95% CI, 0.41 to 0.75; P,0.001) (Figure 2B). Similar results were observed using the CKD- EPI formula (HR, 0.64; 95% CI, 0.48 to 0.85; P=0.006) (Figure 2C). When GFR was measured by the mean of urinary urea and creatinine clearances, the results were similar to the results observed using the CG formula (HR, 1.05; 95% CI, 0.67 to 1.66; P=0.86) (Figure 2D). Patient Survival and egfr Uncorrected for BSA In sensitivity analyses, there was no interaction between egfr formulas and sex for any of the three formulas. When egfr values were uncorrected for BSA, CG-determined egfr at dialysis start was not associated with all-cause mortality, whereas the groups with the lower start egfr determined by MDRD and CKD-EPI egfr values were still significantly associated with lower mortality (Supplemental Figure 1). The Bland and Altman plots were similar to those plots of egfr corrected for BSA, with the closest agreement observed between the MDRD and CKD-EPI estimates of GFR (data not shown). Patient Survival Based on CV and Non-CV Mortality In total, 121 patients died of CV causes, and 154 patients died from non-cv causes. The unadjusted HR of the lowest egfr group estimated by all three formulas was not statistically significant for CV-related death (Table 2). When MDRD and CKD-EPI were used to determine egfr, the lowest egfr tertiles had 58% and 51% lower risks of dying because of non-cv related death, respectively, compared with the highest egfr tertile (reference group) (Table 2). When the causes of non-cv deaths were Figure 1. Bland and Altman plot comparing two different estimated GFR (egfr) formulas in Initiating Dialysis Early and Late participants at dialysis commencement. (A) Comparison between Cockcroft and Gault (CG) and Modification of Diet in Renal Disease (MDRD) formulas. (B) Comparison between CG and Chronic Kidney Disease-Epidemiology Collaboration (CKD-EPI) formulas. (C) Comparison between MDRD and CKD-EPI formulas. The continuous lines represent the mean difference between the two formulas; the dotted lines represent the upper and lower limits of agreement between the two formulas.
5 Clin J Am Soc Nephrol 9: , January, 2014 egfr and Dialysis Survival, Wong et al. 139 Figure 2. Kaplan Meier plots of patient survival based on estimated GFR (egfr) tertile groups by three different formulas or measured mean urinary urea and creatinine clearance at dialysis commencement in Initiating Dialysis Early and Late trial participants. (A) Cockcroft and Gault (CG) egfr: the differences between the groups were not statistically significant (log-rank test: P=0.38). (B) Modification of Diet in Renal Disease (MDRD) egfr: the differences between the groups were highly statistically significant (log-rank test: P,0.001). (C) Chronic Kidney Disease- Epidemiology Collaboration (CKD-EPI) egfr: the differences between the groups were highly statistically significant (log-rank test: P,0.001). (D) Mean urinary urea and creatinine clearance: the differences between the groups were not statistically significant (log-rank test: P=0.86). further analyzed, 42% were attributable to infection, 20% were because of patient initiated withdrawal from dialysis, and 16% were caused by malignancy. Of the infection-related deaths, peritonitis accounted for 14.7%, which was followed by lung infection (12.8%). Patient Survival in Multivariate Adjusted Analysis Using multivariable Cox proportional hazards model analysis, the observed apparent longer survival in the lowest MDRD or CKD-EPI egfr tertiles compared with the highest tertilesofegfratdialysiscommencementwasnolonger significant after adjustment for age, sex, racial origin, body mass index, and comorbidities (Figure 3). Being older, being a woman, and having diabetes or CV disease conferred a higher risk of death (Figure 3). At the time of dialysis commencement, having diabetes mellitus conferred a more than twofold increased risk of death in patients with stage 5 CKD. Discussion The IDEAL trial reported that planned early start dialysis did not result in better clinical outcomes or quality of life but incurred additional cost. The current as-treated analysis of the IDEAL trial using the MDRD or CKD-EPI formulas for GFR estimation at the time of commencement of dialysis showed that those patients who commenced dialysis with a lower egfr experienced longer survival compared with those patients who started dialysis with higher levels of renal function. This result was not seen when GFR was estimated using the CG formula. Although the Kaplan Meier plot clearly showed a longer survival for the lowest egfr tertile when MDRD and CKD-EPI equations were used, this association was no longer statistically significant after adjustment for age, sex, race, body mass index, and comorbidities. This study also supports the observations of other cohort studies using the MDRD egfr in suggesting that patients who commence dialysis with
6 140 Clinical Journal of the American Society of Nephrology Table 2. formula Unadjusted hazard ratios for cardiovascular and noncardiovascular mortality according to GFR tertile groups by each GFR Tertile a Hazard Ratio Lower CI Upper CI P Value CV deaths CG, CG= MDRD, MDRD= CKD-EPI, CKD-EPI= Non-CV deaths CG, CG= MDRD, ,0.001 MDRD= CKD-EPI, ,0.001 CKD-EPI= CI, confidence interval; CV, cardiovascular; CG, Cockcroft and Gault; MDRD, Modification of Diet in Renal Disease; CKD-EPI, Chronic Kidney Disease-Epidemiology Collaboration. a Reference group is the tertile with the highest estimated GFR (CG$12.0 ml/min per 1.73 m 2 ; MDRD$9.0 ml/min per 1.73 m 2 ;CKD- EPI$8.0 ml/min per 1.73 m 2 ). higher levels of renal function are more likely to be older, be women, and have diabetes or CV disease. Hence, these characteristics are more likely to result in a higher risk of dying compared with the characteristics of patients who remain clinically well and biochemically stable and hence, are able to defer the initiation of dialysis until later in the course of CKD. The NECOSAD suggested that this finding may be primarily influenced by an increased muscle mass in healthy patients, resulting in a lower egfr when determined by the MDRD study. Our study did not find that correction of egfr for BSA modified the relationship between egfr and mortality. Only one third of the IDEAL participants had timed urinary collection at the time of dialysis commencement. Despite this limitation, this study was able to replicate the data by the NECOSAD study group that showed a survival advantage in those patients with the lowest renal function measured by MDRD but not GFR was measured by mean urinary urea and creatinine clearances (Figure 2D). Although we could not definitively determine the impact of muscle mass in the estimation of GFR and hence, the association with outcome in this study, our findings reinforced that estimation of GFR by equations using plasma creatinine in the denominator is less likely to be useful in patients with end stage kidney disease, because the plasma creatinine is affected by muscle mass as well as glomerular filtration. Our study also shows that there is a clear trend for patients who start dialysis early to commence on peritoneal dialysis. Thus, the observed initial mortality benefit shown in the peritoneal dialysis cohort (28) may well be influenced by an unmeasured lead time bias rather than a specific benefit of peritoneal dialysis. Before the results of the IDEAL study, guidelines increasingly considered the egfr as a determinant for initiation of dialysis. Hence, the difference in egfr estimated by different formulas and associated clinical outcomes are likely to be of considerable clinical interest. Our results confirm significant reclassification of patients among the tertiles when the MDRD and CKD-EPI formulas were used instead of CG equation to estimate GFR at the commencement of dialysis. The Bland and Altman plots indicate strong agreement between MDRD and CKD-EPI egfr values, but neither had strong agreement with the CG-determined egfr. In the absence of a gold standard measurement GFR, this study is unable to provide information regarding which GFR formula most accurately determines GFR in stage 5 CKD. Recently, many investigators had questioned the validity of using creatinine-based egfr to estimate renal function in patients with stage 5 CKD (29), largely because of the fact that very few patients with stage 5 CKD were included in the original validation cohorts. For instance, the CG equation was derived from 249 patients ages years who were all Caucasian men in an in-patient veterans hospital. The lowest GFR was reported in the 80- to 92-year-old group, with a mean of 37 ml/min per 1.73 m 2 (2,25). The MDRD study included 1070 patients in the development sample and 558 patients in the validation sample, with a mean egfr of 39.8 ml/min per 1.73 m 2 (2,30). Similarly, less than 3% in the validation cohort using the CKD-EPI formula had a GFR,15 ml/min per 1.73 m 2 (2,31). Hence, using creatinine-based egfr to estimate renal function in patients with stage 5 CKD has questionable validity. Moreover, the results of the IDEAL study suggest that there is limited clinical relevance of egfr in stage 5 CKD for guiding decisions regarding renal replacement therapy. The strength of this study was its inclusive nature, which encompassed a variety of centers (metropolitan, regional, and rural as well as general and university) across two countries (Australia and New Zealand). The end points were independently adjudicated by an adjudication committee to reduce bias. However, there are several limitations. Despite randomization, there remains the possibility of misclassification bias, survivor bias, and indication bias with residual confounding (i.e., patients starting dialysis at lower GFR
7 Clin J Am Soc Nephrol 9: , January, 2014 egfr and Dialysis Survival, Wong et al. 141 Figure 3. Forest plot of the association between estimated GFR (egfr) tertiles at dialysis commencement and patient survival in Initiating Dialysis Early and Late trial participants. In multivariable Cox proportional hazards model analyses, patient survival was not significantly associated with egfr at dialysis commencement, regardless of the formula used. Older age, women, diabetes mellitus, and cardiovascular disease at dialysis commencement were associated with a significantly increased hazard of death. Cardiovascular disease was defined as the presence of ischemic heart disease, congestive cardiac failure, peripheral vascular disease, or stroke. BMI, body mass index; C+G, Cockcroft and Gault; CI, confidence interval; CKDEPI, Chronic Kidney Disease-Epidemiology Collaboration; MDRD, Modification of Diet in Renal Disease. values may have had less comorbidity, leading to lower mortality that may not have been adequately adjusted for in multivariable analysis). Because this analysis is an on treatment analysis, lead time bias remains. However, in contrast to other observational studies, all patients in the IDEAL study were under the care of nephrologists before the start of dialysis. This analysis is based on the premise that overall kidney function is a function of GFR calculated using various GFR formulas. It has not addressed other key physiologic kidney functions, which may not decline in parallel to GFR. Because there were only a few participants with timed urinary collection at the time of dialysis commencement, this study was unable to determine whether measurement of mean urinary urea and creatinine clearances provided additional useful clinical information in patients with stage 5 CKD. Our limited results suggest that this is not the case. In conclusion, these data suggest that there are discrepancies between estimations of GFR using the available formulas in patients with stage 5 CKD independent of BSA. More importantly, the timing of dialysis, which was determined by egfr, does not impact on survival after conventional risk factors, such as age, sex, diabetes, and CV risk factors, are taken into account. The results are consistent across most populations, including those groups historically considered likely to benefit most from early start dialysis,namely the elderly and diabetic cohorts. Moreover, patients who commenced dialysis at higher MDRD or CKD-EPI egfr values are more likely to die because of non-cv related mortality, which is mostly related to dialysis-related complications, such as peritonitis and withdrawal of dialysis. The latter is consistent with a recent report from Canadian registry data (32). These data support the conclusions of the IDEAL trial that the decision to initiate dialysis should be based on clinical judgment rather than solely egfr. The appropriateness and applicability of measuring egfr in stage 5 CKD should be reconsidered by the nephrological community.
8 142 Clinical Journal of the American Society of Nephrology Acknowledgments The Initiating Dialysis Early and Late (IDEAL) study was an investigator-initiated and -conducted study funded by National Health and Medical Research Council of Australia Grants and , Australian Health Ministers Advisory Council Grant PDR 2001/10, the Royal Australasian College of Physicians/Australian and New Zealand Society of Nephrology (Don and Lorraine Jacquot Fellowship; 2001 and 2012), the National Heart Foundation (Australia; 2003), and the National Heart Foundation (New Zealand; 2003). The IDEAL trial was supported by unrestricted grants from Baxter Healthcare Corporation, the Health Funding Authority New Zealand (Te Mana Putea Hauora O Aotearoa), the International Society for Peritoneal Dialysis, Amgen Australia Pty Ltd, and Janssen Cilag Pty Ltd. Disclosures C.P. chairs a clinical trial steering committee for Baxter and is a member of an advisory committee for Amgen. The other authors have nothing to disclose. References 1. Bonomini V, Baldrati L, Stefoni S: Comparative cost/benefit analysis in early and late dialysis. Nephron 33: 1 4, Bonomini V, Albertazzi A, Vangelista A, Bortolotti GC, Stefoni S, Scolari MP: Residual renal function and effective rehabilitation in chronic dialysis. Nephron 16: , Bonomini V, Feletti C, Scolari MP, Stefoni S: Benefits of early initiation of dialysis. Kidney Int Suppl 17: S57 S59, Jungers P, Zingraff J, Albouze G, Chauveau P, Page B, Hannedouche T, Man NK: Late referral to maintenance dialysis: Detrimental consequences. Nephrol Dial Transplant 8: , Jungers P, Zingraff J, Page B, Albouze G, Hannedouche T, Man NK: Detrimental effects of late referral in patients with chronic renal failure: A case-control study. Kidney Int Suppl 41: S170 S173, McCusker FX, Teehan BP, Thorpe KE, Keshaviah PR, Churchill DN: How much peritoneal dialysis is required for the maintenance of a good nutritional state? Canada-USA (CANUSA) Peritoneal Dialysis Study Group. Kidney Int Suppl 56: S56 S61, Sesso R, Belasco AG: Late diagnosis of chronic renal failure and mortality on maintenance dialysis. Nephrol Dial Transplant 11: , Tattersall J, Greenwood R, Farrington K: Urea kinetics and when to commence dialysis. Am J Nephrol 15: , Churchill DN: An evidence-based approach to earlier initiation of dialysis. Am J Kidney Dis 30: , Golper TA: The rationale for Healthy Start dialysis. Blood Purif 17: 1 9, Susantitaphong P, Altamimi S, Ashkar M, Balk EM, Stel VS, Wright S, Jaber BL: GFR at initiation of dialysis and mortality in CKD: A meta-analysis. Am J Kidney Dis 59: , Traynor JP, Simpson K, Geddes CC, Deighan CJ, Fox JG: Early initiation of dialysis fails to prolong survival in patients with endstage renal failure. J Am Soc Nephrol 13: , Clark WF, Na Y, Rosansky SJ, Sontrop JM, Macnab JJ, Glassock RJ, Eggers PW, Jackson K, Moist L: Association between estimated glomerular filtration rate at initiation of dialysis and mortality. CMAJ 183: 47 53, Kazmi WH, Gilbertson DT, Obrador GT, Guo H, Pereira BJ, Collins AJ, Kausz AT: Effect of comorbidity on the increased mortality associated with early initiation of dialysis. Am J Kidney Dis 46: , Stel VS, Dekker FW, Ansell D, Augustijn H, Casino FG, Collart F, Finne P, Ioannidis GA, Salomone M, Traynor JP, Zurriaga O, Verrina E, Jager KJ: Residual renal function at the start of dialysis and clinical outcomes. Nephrol Dial Transplant 24: , Lassalle M, Labeeuw M, Frimat L, Villar E, Joyeux V, Couchoud C, Stengel B: Age and comorbidity may explain the paradoxical association of an early dialysis start with poor survival. Kidney Int 77: , Wright S, Klausner D, Baird B, Williams ME, Steinman T, Tang H, Ragasa R, Goldfarb-Rumyantzev AS: Timing of dialysis initiation and survival in ESRD. Clin J Am Soc Nephrol 5: , Hwang SJ, Yang WC, Lin MY, Mau LW, Chen HC; Taiwan Society of Nephrology: Impact of the clinical conditions at dialysis initiation on mortality in incident haemodialysis patients: A national cohort study in Taiwan. Nephrol Dial Transplant 25: , Fink JC, Burdick RA, Kurth SJ, Blahut SA, Armistead NC, Turner MS, Shickle LM, Light PD: Significance of serum creatinine values in new end-stage renal disease patients. Am J Kidney Dis 34: , Sawhney S, Djurdjev O, Simpson K, Macleod A, Levin A: Survival and dialysis initiation: Comparing British Columbia and Scotland registries. Nephrol Dial Transplant 24: , Grootendorst DC, Michels WM, Richardson JD, Jager KJ, Boeschoten EW, Dekker FW, Krediet RT; NECOSAD Study Group: The MDRD formula does not reflect GFR in ESRD patients. Nephrol Dial Transplant 26: , Rosansky SJ, Eggers P, Jackson K, Glassock R, Clark WF: Early start of hemodialysis may be harmful. Arch Intern Med 171: , Cooper BA, Branley P, Bulfone L, Collins JF, Craig JC, Fraenkel MB, Harris A, Johnson DW, Kesselhut J, Li JJ, Luxton G, Pilmore A, Tiller DJ, Harris DC, Pollock CA; IDEAL Study: A randomized, controlled trial of early versus late initiation of dialysis. NEnglJ Med 363: , Harris A, Cooper BA, Li JJ, Bulfone L, Branley P, Collins JF, Craig JC, Fraenkel MB, Johnson DW, Kesselhut J, Luxton G, Pilmore A, Rosevear M, Tiller DJ, Pollock CA, Harris DC: Cost-effectiveness of initiating dialysis early: A randomized controlled trial. Am J Kidney Dis 57: , Cockcroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron 16: 31 41, Du Bois D, Du Bois EF: A formula to estimate the approximate surface area if height and weight be known Nutrition 5: , Levey AS, Stevens LA: Estimating GFR using the CKD Epidemiology Collaboration (CKD-EPI) creatinine equation: More accurate GFR estimates, lower CKD prevalence estimates, and better risk predictions. Am J Kidney Dis 55: , Chan KE, Maddux FW, Tolkoff-Rubin N, Karumanchi SA, Thadhani R, Hakim RM: Early outcomes among those initiating chronic dialysis in the United States. Clin J Am Soc Nephrol 6: , White CA, Akbari A: The estimation, measurement, and relevance of the glomerular filtration rate in stage 5 chronic kidney disease. Semin Dial 24: , Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D; Modification of Diet in Renal Disease Study Group: A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Ann Intern Med 130: , Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration): A new equation to estimate glomerular filtration rate. Ann Intern Med 150: , Ellwood AD, Jassal SV, Suri RS, Clark WF, Na Y, Moist LM: Early dialysis initiation and rates and timing of withdrawal from dialysis in Canada. Clin J Am Soc Nephrol 8: , 2013 Received: February 25, 2013 Accepted: September 5, 2013 Published online ahead of print. Publication date available at www. cjasn.org. This article contains supplemental material online at asnjournals.org/lookup/suppl/doi: /cjn /-/ DCSupplemental.
The CARI Guidelines Caring for Australians with Renal Impairment. Level of renal function at which to initiate dialysis GUIDELINES
Level of renal function at which to initiate dialysis Date written: September 2004 Final submission: February 2005 GUIDELINES No recommendations possible based on Level I or II evidence SUGGESTIONS FOR
More informationThe Effect of Residual Renal Function at the Initiation of Dialysis on Patient Survival
ORIGINAL ARTICLE DOI: 10.3904/kjim.2009.24.1.55 The Effect of Residual Renal Function at the Initiation of Dialysis on Patient Survival Seoung Gu Kim 1 and Nam Ho Kim 2 Department of Internal Medicine,
More informationEarly Initiation of Dialysis Fails to Prolong Survival in Patients with End-Stage Renal Failure
J Am Soc Nephrol 13: 2125 2132, 2002 Early Initiation of Dialysis Fails to Prolong Survival in Patients with End-Stage Renal Failure JAMIE P. TRAYNOR,* KEITH SIMPSON,* COLIN C. GEDDES, CHRISTOPHER J. DEIGHAN,*
More informationImpact of Timing of Initiation of Dialysis on Mortality
J Am Soc Nephrol 14: 2305 2312, 2003 Impact of Timing of Initiation of Dialysis on Mortality SRINIVASAN BEDDHU,* MATTHEW H. SAMORE, MARK S. ROBERTS, GREGORY J. STODDARD, NIRUPAMA RAMKUMAR, LISA M. PAPPAS,
More informationWHEN (AND WHEN NOT) TO START DIALYSIS. Shahid Chandna, Ken Farrington
WHEN (AND WHEN NOT) TO START DIALYSIS Shahid Chandna, Ken Farrington Changing Perspectives Beta blockers 1980s Contraindicated in heart failure Now mainstay of therapy HRT 1990s must Now only if you have
More informationAge may explain the association of an early dialysis initiation with poor survival
Q J Med 2014; 107:879 886 doi:10.1093/qjmed/hcu105 Advance Access Publication 22 May 2014 Age may explain the association of an early dialysis initiation with poor survival M.J. SOLER 1,2, *, N. MONTERO
More informationDespite the widespread use of chronic dialysis, there
Timing of Dialysis Initiation and Survival in ESRD Seth Wright,* Dalia Klausner, Bradley Baird, Mark E. Williams, Theodore Steinman, Hongying Tang, Regina Ragasa, and Alexander S. Goldfarb-Rumyantzev *Department
More informationABSTRACT. n engl j med 363;7 nejm.org august 12,
The new england journal of medicine established in 1812 august 12, 2010 vol. 363 no. 7 A Randomized, Controlled Trial of Early versus Late Initiation of Dialysis Bruce A. Cooper, M.B., B.S., Ph.D., Pauline
More informationWhen to start dialysis?
Nephrol Dial Transplant (2006) 21 [Suppl 2]: ii20 ii24 doi:10.1093/ndt/gfl139 Original Article When to start dialysis? C. E. Douma 1 and W. Smit 2 1 Department of Nephrology, VU University Medical Center,
More informationThe timing of dialysis initiation affects the incidence of renal replacement therapy Cécile Couchoud appliquées Paris 5
The timing of dialysis initiation affects the incidence of renal replacement therapy Cécile Couchoud appliquées Paris * REIN Registry Agence de la biomé decine CNRS : UMR814, Universit é Paris Descartes
More informationThe EQUAL study: a European study in chronic kidney disease stage 4 patients
Nephrol Dial Transplant (2012) 27 (Supple 3): iii27 iii31 doi: 10.1093/ndt/gfs277 Advance Access publication 4 July 2012 Editorial Review The EQUAL study: a European study in chronic kidney disease stage
More informationEarly Start of Dialysis Has No Survival Benefit in End-Stage Renal Disease Patients
ORIGINAL ARTICLE Nephrology http://dx.doi.org/10.3346/jkms.2012.27.10.1177 J Korean Med Sci 2012; 27: 1177-1181 Early Start of Dialysis Has No Survival Benefit in End-Stage Renal Disease atients Jae Hyun
More informationThe CARI Guidelines Caring for Australians with Renal Impairment. Other criteria for starting dialysis GUIDELINES
Date written: September 2004 Final submission: February 2005 Other criteria for starting dialysis GUIDELINES No recommendations possible based on Level I or II evidence SUGGESTIONS FOR CLINICAL CARE (Suggestions
More informationIs the new Mayo Clinic Quadratic (MCQ) equation useful for the estimation of glomerular filtration rate in type 2 diabetic patients?
Diabetes Care Publish Ahead of Print, published online October 3, 2008 The MCQ equation in DM2 patients Is the new Mayo Clinic Quadratic (MCQ) equation useful for the estimation of glomerular filtration
More informationImpact of timing of initiation of dialysis on long term prognosis of patients undergoing hemodialysis
EXPERIMENTAL AND THERAPEUTIC MEDICINE 16: 1209-1215, 2018 Impact of timing of initiation of dialysis on long term prognosis of patients undergoing hemodialysis YUMEI ZHANG *, CHUN HU *, ZHIXIANG BIAN and
More informationEffect of previously failed kidney transplantation on peritoneal dialysis outcomes in the Australian and New Zealand patient populations
NDT Advance Access published November 9, 2005 Nephrol Dial Transplant (2005) 1 of 8 doi:10.1093/ndt/gfi248 Original Article Effect of previously failed kidney transplantation on peritoneal dialysis outcomes
More informationThe estimation of kidney function with different formulas in overall population
137 G E R I A T R I A 213; 7: 137-141 Akademia Medycyny ARTYKUŁ ORYGINALNY/ORIGINAL PAPER Otrzymano/Submitted: 28.8.213 Zaakceptowano/Accepted: 2.9.213 The estimation of kidney function with different
More informationWhen to initiate dialysis is an early start always better?
Nephrol Dial Transplant (2011) 26: 2087 2091 doi: 10.1093/ndt/gfr181 Advance Access publication 4 May 2011 Editorial Reviews When to initiate dialysis is an early start always better? Tomasz Liberek 1,
More informationORIGINAL INVESTIGATION. Frailty, Dialysis Initiation, and Mortality in End-Stage Renal Disease
ORIGINAL INVESTIGATION ty, Dialysis Initiation, and Mortality in End-Stage Renal Disease Yeran Bao, MD; Lorien Dalrymple, MD, MPH; Glenn M. Chertow, MD, MPH; George A. Kaysen, MD, PhD; Kirsten L. Johansen,
More informationAssociation between causes of peritoneal dialysis technique failure and all-cause mortality
www.nature.com/scientificreports Received: 27 September 2017 Accepted: 21 February 2018 Published: xx xx xxxx OPEN Association between causes of peritoneal dialysis technique failure and all-cause mortality
More informationThe CARI Guidelines Caring for Australians with Renal Impairment. Cardiovascular Risk Factors
Cardiovascular Risk Factors ROB WALKER (Dunedin, New Zealand) Lipid-lowering therapy in patients with chronic kidney disease Date written: January 2005 Final submission: August 2005 Author: Rob Walker
More informationChapter 1: CKD in the General Population
Chapter 1: CKD in the General Population Overall prevalence of CKD (Stages 1-5) in the U.S. adult general population was 14.8% in 2011-2014. CKD Stage 3 is the most prevalent (NHANES: Figure 1.2 and Table
More informationThe optimal time to commence dialysis in
PERITONEAL DIALYSIS Early Start Peritoneal Dialysis Carol A. Pollock, Bruce A. Cooper, and David C. Harris The timing of commencement of dialysis is controversial, as it has an impact on the patient s
More informationW J N. World Journal of Nephrology. When to initiate renal replacement therapy: The trend of dialysis initiation. Abstract MINIREVIEWS
W J N World Journal of Nephrology Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5527/wjn.v4.i5.521 World J Nephrol 2015 November 6; 4(5):
More informationPART ONE. Peritoneal Kinetics and Anatomy
PART ONE Peritoneal Kinetics and Anatomy Advances in Peritoneal Dialysis, Vol. 22, 2006 Paul A. Fein, Irfan Fazil, Muhammad A. Rafiq, Teresa Schloth, Betty Matza, Jyotiprakas Chattopadhyay, Morrell M.
More informationAssessment of glomerular filtration rate in healthy subjects and normoalbuminuric diabetic patients: validity of a new (MDRD) prediction equation
Nephrol Dial Transplant (2002) 17: 1909 1913 Original Article Assessment of glomerular filtration rate in healthy subjects and normoalbuminuric diabetic patients: validity of a new () prediction equation
More informationChronic kidney disease (CKD) has received
Participant Follow-up in the Kidney Early Evaluation Program (KEEP) After Initial Detection Allan J. Collins, MD, FACP, 1,2 Suying Li, PhD, 1 Shu-Cheng Chen, MS, 1 and Joseph A. Vassalotti, MD 3,4 Background:
More informationCHRONIC DIALYSIS IS AN INtensive
LESS IS MORE ORIGINAL INVESTIGATION Trends in Timing of Initiation of Chronic Dialysis in the United States Ann M. O Hare, MD, MA; Andy I. Choi, MD, MS ; W. John Boscardin, PhD; Walter L. Clinton, PhD;
More informationValidation of El-Minia Equation for Estimation of Glomerular Filtration Rate in Different Stages of Chronic Kidney Disease
Kidney Diseases Validation of El-Minia Equation for Estimation of Glomerular Filtration Rate in Different Stages of Chronic Kidney Disease Osama El Minshawy, 1 Eman El-Bassuoni 2 Original Paper 1 Department
More informationegfr > 50 (n = 13,916)
Saxagliptin and Cardiovascular Risk in Patients with Type 2 Diabetes Mellitus and Moderate or Severe Renal Impairment: Observations from the SAVOR-TIMI 53 Trial Supplementary Table 1. Characteristics according
More informationProtocol. This trial protocol has been provided by the authors to give readers additional information about their work.
Protocol This trial protocol has been provided by the authors to give readers additional information about their work. Protocol for: Cooper BA, Branley P, Bulfone L, et al. A randomized, controlled trial
More informationSpecial Challenges and Co-Morbidities
Special Challenges and Co-Morbidities Renal Disease/ Hypertension/ Diabetes in African-Americans M. Keith Rawlings, MD Medical Director Peabody Health Center AIDS Arms, Inc Dallas, TX Chair, Internal Medicine
More informationTrends in Timing of Dialysis Initiation within Versus Outside the Department of Veterans Affairs
Article Trends in Timing of Dialysis Initiation within Versus Outside the Department of Veterans Affairs Margaret K. Yu,* Ann M. O Hare,* Adam Batten,* Christine A. Sulc,* Emily L. Neely,* Chuan-Fen Liu,*
More informationThe CARI Guidelines Caring for Australians with Renal Impairment. Mode of dialysis at initiation GUIDELINES
Date written: September 2004 Final submission: February 2005 Mode of dialysis at initiation GUIDELINES No recommendations possible based on Level I or II evidence SUGGESTIONS FOR CLINICAL CARE (Suggestions
More informationImprovement in Pittsburgh Symptom Score Index After Initiation of Peritoneal Dialysis
Advances in Peritoneal Dialysis, Vol. 24, 2008 Matthew J. Novak, 1 Heena Sheth, 2 Filitsa H. Bender, 1 Linda Fried, 1,3 Beth Piraino 1 Improvement in Pittsburgh Symptom Score Index After Initiation of
More informationDifference in practical dialysis therapy between East Asia and US/EU
Difference in practical dialysis therapy between East Asia and US/EU Jer-Ming Chang. M.D., Ph.D. 1 Professor, Attending physician, Kaohsiung Medical University Hospital; 2 Secretary General, Taiwan Society
More informationHome Hemodialysis or Transplantation of the Treatment of Choice for Elderly?
Home Hemodialysis or Transplantation of the Treatment of Choice for Elderly? Miklos Z Molnar, MD, PhD, FEBTM, FERA, FASN Associate Professor of Medicine Division of Nephrology, Department of Medicine University
More informationORIGINAL INVESTIGATION. Serum Creatinine Is an Inadequate Screening Test for Renal Failure in Elderly Patients
ORIGINAL INVESTIGATION Serum Creatinine Is an Inadequate Screening Test for Renal Failure in Elderly Patients Peter J. Swedko, MD; Heather D. Clark, MD, CM, MSc; Koushi Paramsothy, MD; Ayub Akbari, MD
More informationChapter 5: Acute Kidney Injury
Chapter 5: Acute Kidney Injury Introduction In recent years, acute kidney injury (AKI) has gained increasing recognition as a major risk factor for the development of chronic kidney disease (CKD). The
More informationNephrology. Renal Replacement in End-Stage Renal Disease Patients over 75 Years Old. ABC Fax
American Journal of Nephrology Original Article: Basic Sciences Am J Nephrol 2003;23:7 77 DOI: 0.59/000068040 Received: July 23, 2002 Accepted: October 2, 2002 Renal Replacement in End-Stage Renal Disease
More informationIntravenous Iron Does Not Affect the Rate of Decline of Residual Renal Function in Patients on Peritoneal Dialysis
Advances in Peritoneal Dialysis, Vol. 22, 2006 Hemal Shah, Ashutosh Shukla, Abirami Krishnan, Theodore Pliakogiannis, Mufazzal Ahmad, Joanne M. Bargman, Dimitrios G. Oreopoulos Intravenous Iron Does Not
More informationObjectives. Pre-dialysis CKD: The Problem. Pre-dialysis CKD: The Problem. Objectives
The Role of the Primary Physician and the Nephrologist in the Management of Chronic Kidney Disease () By Brian Young, M.D. Assistant Clinical Professor of Medicine David Geffen School of Medicine at UCLA
More informationExcess mortality due to interaction between proteinenergy wasting, inflammation and cardiovascular disease in chronic dialysis patients
7 Excess mortality due to interaction between proteinenergy wasting, inflammation and cardiovascular disease in chronic dialysis patients R. de Mutsert D.C. Grootendorst J. Axelsson E.W. Boeschoten R.T.
More informationLucia Cea Soriano 1, Saga Johansson 2, Bergur Stefansson 2 and Luis A García Rodríguez 1*
Cea Soriano et al. Cardiovascular Diabetology (2015) 14:38 DOI 10.1186/s12933-015-0204-5 CARDIO VASCULAR DIABETOLOGY ORIGINAL INVESTIGATION Open Access Cardiovascular events and all-cause mortality in
More informationImplications of the CKD-EPI GFR Estimation Equation in Clinical Practice
Article Implications of the CKD-EPI GFR Estimation Equation in Clinical Practice Jesse D. Schold,* Sankar D. Navaneethan, Stacey E. Jolly, Emilio D. Poggio, Susana Arrigain,* Welf Saupe, Anil Jain, John
More informationMeasure Abbreviation: AKI 01 (QCDR Measure ID: ASPIRE19)
Measure Abbreviation: AKI 01 (QCDR Measure ID: ASPIRE19) Data Collection Method: This measure is calculated based on data extracted from the electronic medical record combined with administrative data
More informationElevation of Serum Creatinine: When to Screen, When to Refer. Bruce F. Culleton, MD, FRCPC; and Jolanta Karpinski, MD, FRCPC
Elevation of Serum Creatinine: When to Screen, When to Refer Bruce F. Culleton, MD, FRCPC; and Jolanta Karpinski, MD, FRCPC Presented at the University of Calgary s CME and Professional Development 2006-2007
More informationUSRDS UNITED STATES RENAL DATA SYSTEM
USRDS UNITED STATES RENAL DATA SYSTEM Chapter 2: Identification and Care of Patients With CKD Over half of patients from the Medicare 5 percent sample have either a diagnosis of chronic kidney disease
More informationChronic Kidney Disease: Optimal and Coordinated Management
Chronic Kidney Disease: Optimal and Coordinated Management Michael Copland, MD, FRCPC Presented at University of British Columbia s 42nd Annual Post Graduate Review in Family Medicine Conference, Vancouver,
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Wanner C, Inzucchi SE, Lachin JM, et al. Empagliflozin and
More informationAJNT. Original Article
. 2012 May;5(2):81-6 Original Article AJNT Reaching Target Hemoglobin Level and Having a Functioning Arteriovenous Fistula Significantly Improve One Year Survival in Twice Weekly Hemodialysis Sarra Elamin
More informationRepercussions of early versus late initiation of dialysis
http://www.revistanefrologia.com 2011 Revista Nefrología. Órgano Oficial de la Sociedad Española de Nefrología Repercussions of early versus late initiation of dialysis L.M. Ortega, A. Nayer Division of
More informationSerum uric acid levels improve prediction of incident Type 2 Diabetes in individuals with impaired fasting glucose: The Rancho Bernardo Study
Diabetes Care Publish Ahead of Print, published online June 9, 2009 Serum uric acid and incident DM2 Serum uric acid levels improve prediction of incident Type 2 Diabetes in individuals with impaired fasting
More informationThe Seventh Report of the Joint National Commission
The Effect of a Lower Target Blood Pressure on the Progression of Kidney Disease: Long-Term Follow-up of the Modification of Diet in Renal Disease Study Mark J. Sarnak, MD; Tom Greene, PhD; Xuelei Wang,
More informationTrial to Reduce. Aranesp* Therapy. Cardiovascular Events with
Trial to Reduce Cardiovascular Events with Aranesp* Therapy John J.V. McMurray, Hajime Uno, Petr Jarolim, Akshay S. Desai, Dick de Zeeuw, Kai-Uwe Eckardt, Peter Ivanovich, Andrew S. Levey, Eldrin F. Lewis,
More informationEvaluation of the Cockroft Gault, Jelliffe and Wright formulae in estimating renal function in elderly cancer patients
Original article Annals of Oncology 15: 291 295, 2004 DOI: 10.1093/annonc/mdh079 Evaluation of the Cockroft Gault, Jelliffe and Wright formulae in estimating renal function in elderly cancer patients G.
More information( ) , (Donabedian, 1980) We would not choose any treatment with poor outcomes
..., 2013 Amgen. 1 ? ( ), (Donabedian, 1980) We would not choose any treatment with poor outcomes 1. :, 2. ( ): 3. :.,,, 4. :, [Biomarkers Definitions Working Group, 2001]., (William M. Bennet, Nefrol
More informationAcknowledgements. National Kidney Foundation of Connecticut Mark Perazella. Co-PI Slowing the progression of chronic kidney disease to ESRD
A Practical Approach to Chronic Kidney Disease Management for the Primary Care Practioner: A web-site sponsored by the National Kidney Foundation of Connecticut Robert Reilly, M.D. Acknowledgements National
More informationPrincess Alexandra Hospital, Brisbane
Princess Alexandra Hospital Coagulase Negative Staphylococcal Peritonitis in Australian Peritoneal Dialysis Patients Predictors, Treatment and Outcomes in 936 cases Dr Magid Fahim Princess Alexandra Hospital,
More informationPredictive Factors for Withdrawal from Peritoneal Dialysis: A Retrospective Cohort Study at Two Centers in Japan
Advances in Peritoneal Dialysis, Vol. 33, 2017 Yasuhiro Taki, 1 Tsutomu Sakurada, 2 Kenichiro Koitabashi, 2 Naohiko Imai, 1 Yugo Shibagaki 2 Predictive Factors for Withdrawal from Peritoneal Dialysis:
More informationNarender Goel et al. Middletown Medical PC, Montefiore Medical Center & Albert Einstein College of Medicine, New York
Narender Goel et al. Middletown Medical PC, Montefiore Medical Center & Albert Einstein College of Medicine, New York 4th International Conference on Nephrology & Therapeutics September 14, 2015 Baltimore,
More informationChapter 2: Identification and Care of Patients With CKD
Chapter 2: Identification and Care of Patients With Over half of patients from the Medicare 5% sample (restricted to age 65 and older) have a diagnosis of chronic kidney disease (), cardiovascular disease,
More informationChronic kidney disease (CKD) affects more than 26
A Simple Tool to Predict End-Stage Renal Disease within 1 Year in Elderly Adults with Advanced Chronic Kidney Disease Paul E. Drawz, MD, MHS, MS,* Puja Goswami, MD, Reem Azem, BA, Denise C. Babineau, PhD,
More informationAcceptance onto dialysis guidelines: St George Hospital
Acceptance onto dialysis guidelines: St George Hospital The following information is a guideline to support clinicians in decision making regarding acceptance onto dialysis. A review of international guidelines
More informationScreening and early recognition of CKD. John Ngigi (FISN) Kidney specialist
Screening and early recognition of CKD John Ngigi (FISN) Kidney specialist screening Why? Who? When? How? Primary diagnosis for patients who start dialysis Other 10% Glomerulonephritis 13% No. of dialysis
More informationConcept and General Objectives of the Conference: Prognosis Matters. Andrew S. Levey, MD Tufts Medical Center Boston, MA
Concept and General Objectives of the Conference: Prognosis Matters Andrew S. Levey, MD Tufts Medical Center Boston, MA General Objectives Topics to discuss What are the key outcomes of CKD? What progress
More informationALLHAT RENAL DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED INTO 4 GROUPS BY BASELINE GLOMERULAR FILTRATION RATE (GFR)
1 RENAL DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED INTO 4 GROUPS BY BASELINE GLOMERULAR FILTRATION RATE (GFR) 6 / 5 / 1006-1 2 Introduction Hypertension is the second most common cause of end-stage
More informationGFR prediction using the MDRD and Cockcroft and Gault equations in patients with end-stage renal disease
Nephrol Dial Transplant (2005) 20: 2394 2401 doi:10.1093/ndt/gfi076 Advance Access publication 23 August 2005 Original Article GFR prediction using the MDRD and Cockcroft and Gault equations in patients
More informationResearch Article. egfr-the BETTER PREDICTOR IN CKD IN INDIAN POPULATION
International Journal of Research and Development in Pharmacy and Life Sciences Available online at http//www.ijrdpl.com June - July, 2016, Vol. 5, No.4, pp 2226-2231 ISSN (P): 2393-932X, ISSN (E): 2278-0238
More informationLong-term outcomes in nondiabetic chronic kidney disease
original article http://www.kidney-international.org & 28 International Society of Nephrology Long-term outcomes in nondiabetic chronic kidney disease V Menon 1, X Wang 2, MJ Sarnak 1, LH Hunsicker 3,
More informationHaemodiafiltration - the case against. Prof Peter G Kerr Professor/Director of Nephrology Monash Health
Haemodiafiltration - the case against Prof Peter G Kerr Professor/Director of Nephrology Monash Health Know your opposition.. Haemodiafiltration NB: pre or post-dilution What is HDF how is it different
More informationAdvances in Peritoneal Dialysis, Vol. 23, 2007
Advances in Peritoneal Dialysis, Vol. 23, 2007 Antonios H. Tzamaloukas, 1,2 Aideloje Onime, 1,2 Dominic S.C. Raj, 2 Glen H. Murata, 1 Dorothy J. VanderJagt, 3 Karen S. Servilla 1,2 Computation of the Dose
More informationChapter 13 The UK Renal Registry Advanced CKD Study: frequency of incorrect reporting of date of start of RRT
Chapter 13 The UK Renal Registry Advanced CKD Study: frequency of incorrect reporting of date of start of RRT Daniel J Ford a, Damian G Fogarty b, Retha Steenkamp a, Charles RV Tomson a, Yoav Ben-Shlomo
More informationAssessing Creatinine Clearance from Modification of Diet in Renal Disease Study Equations in the ADEMEX Cohort: Limitations and Potential Applications
Article Assessing Creatinine Clearance from Modification of Diet in Renal Disease Study Equations in the ADEMEX Cohort: Limitations and Potential Applications James A. Sloand,* John K. Leypoldt,* Bruce
More informationImproved survival of type 2 diabetic patients on renal replacement therapy in Finland
Nephrol Dial Transplant (2010) 25: 892 896 doi: 10.1093/ndt/gfp555 Advance Access publication 21 October 2009 Improved survival of type 2 diabetic patients on renal replacement therapy in Finland Marjo
More informationRisk for chronic kidney disease increases with obesity: Health Survey for England 2010
Public Health Nutrition: 18(18), 3349 3354 doi:10.1017/s1368980015000488 Risk for chronic kidney disease increases with obesity: Health Survey for England 2010 Helen L MacLaughlin 1,2, *, Wendy L Hall
More informationNowadays, many centers rely on estimating equations
Renal Function Equations before and after Living Kidney Donation: A Within-Individual Comparison of Performance at Different Levels of Renal Function Hilde Tent,* Mieneke Rook,* Lesley A. Stevens, Willem
More informationEnvironmental Variability
1 Environmental Variability Body Size, Body Composition, Maturation and Organ Function Nick Holford Dept Pharmacology & Clinical Pharmacology University of Auckland 2 Objectives Understand the major sources
More informationNew Clinical Trends in Geriatric Medicine. April 8, 2016 Amanda Lathia, MD, MPhil Staff, Center for Geriatric Medicine
New Clinical Trends in Geriatric Medicine April 8, 2016 Amanda Lathia, MD, MPhil Staff, Center for Geriatric Medicine Objectives Review current guidelines for blood pressure (BP) control in older adults
More informationChronic Kidney Disease Prevalence and Rate of Diagnosis
The American Journal of Medicine (2007) 120, 981-986 CLINICAL RESEARCH STUDY Chronic Kidney Disease Prevalence and Rate of Diagnosis Timothy P. Ryan, PhD, a James A. Sloand, MD, b Paul C. Winters, MS,
More informationThe CARI Guidelines Caring for Australasians with Renal Impairment. Biochemical Targets. Calcium GUIDELINES
Date written: August 2005 Final submission: October 2005 Author: Carmel Hawley Biochemical Targets CARMEL HAWLEY (Woolloongabba, Queensland) GRAHAME ELDER (Westmead, New South Wales) Calcium GUIDELINES
More informationKrediet slide di 18
1 di 18 Assessment of fluid status in PD patients Raymond T. Krediet, Amsterdam, Netherlands Chairs:Walther H. Boer, Utrecht, The Netherlands F. Fevzi Ersoy, Antalya, Turkey Prof. Raymond T. Krediet DDivision
More informationIndividual Study Table Referring to Part of Dossier: Volume: Page:
Synopsis Abbott Laboratories Name of Study Drug: Paricalcitol Capsules (ABT-358) (Zemplar ) Name of Active Ingredient: Paricalcitol Individual Study Table Referring to Part of Dossier: Volume: Page: (For
More informationPeritoneal Dialysis Adequacy: Not Just Small- Solute Clearance
Advances in Peritoneal Dialysis, Vol. 24, 2008 Rajesh Yalavarthy, Isaac Teitelbaum Peritoneal Dialysis Adequacy: Not Just Small- Solute Clearance Two indices of small-solute clearance, Kt/V urea and creatinine
More information1. Albuminuria an early sign of glomerular damage and renal disease. albuminuria
1. Albuminuria an early sign of glomerular damage and renal disease albuminuria Cardio-renal continuum REGRESS Target organ damage Asymptomatic CKD New risk factors Atherosclerosis Target organ damage
More informationGALECTIN-3 PREDICTS LONG TERM CARDIOVASCULAR DEATH IN HIGH-RISK CORONARY ARTERY DISEASE PATIENTS
GALECTIN-3 PREDICTS LONG TERM CARDIOVASCULAR DEATH IN HIGH-RISK CORONARY ARTERY DISEASE PATIENTS Table of Contents List of authors pag 2 Supplemental figure I pag 3 Supplemental figure II pag 4 Supplemental
More informationThe impact of albuminuria and cardiovascular risk factors on renal function Verhave, Jacoba Catharijne
University of Groningen The impact of albuminuria and cardiovascular risk factors on renal function Verhave, Jacoba Catharijne IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's
More informationQuantification of the Early Risk of Death in Elderly Kidney Transplant Recipients
Wiley Periodicals Inc. C Copyright 2012 The American Society of Transplantation and the American Society of Transplant Surgeons Quantification of the Early Risk of Death in Elderly Kidney Transplant Recipients
More informationDepartment of Clinical Pathology, Faculty of Medicine Padjadjaran University-Dr. Hasan Sadikin General Hospital 2
Original Article Comparison of Estimated Glomerular Filtration Rate Mean Value of HARUS 15-30-60, HADI, and ASIAN Fomula Accuracy in Diabetes Mellitus Type 2 Sylvia Rachmayati, 1 Ida Parwati, 1 Abdul Hadi
More informationOutcomes of dialysis in the elderly. DNT March 2011 Dr Céline Foote
Outcomes of dialysis in the elderly DNT March 2011 Dr Céline Foote Increasing number of elderly patients on renal replacement therapy 500 500 Patients per million 400 300 200 100 400 300 200 100 TOTAL
More informationPrevalence of anemia and cardiovascular diseases in chronic kidney disease patients: a single tertiary care centre study
International Journal of Advances in Medicine Sathyan S et al. Int J Adv Med. 2017 Feb;4(1):247-251 http://www.ijmedicine.com pissn 2349-3925 eissn 2349-3933 Original Research Article DOI: http://dx.doi.org/10.18203/2349-3933.ijam20170120
More informationIntroduction of the CKD-EPI equation to estimate glomerular filtration rate in a Caucasian population
3176 Nephrol Dial Transplant (2011) 26: 3176 3181 doi: 10.1093/ndt/gfr003 Advance Access publication 16 February 2011 Introduction of the CKD-EPI equation to estimate glomerular filtration rate in a Caucasian
More informationInterventions to reduce progression of CKD what is the evidence? John Feehally
Interventions to reduce progression of CKD what is the evidence? John Feehally Interventions to reduce progression of CKD what is the evidence? CHALLENGES Understanding what we know. NOT.what we think
More informationSerum creatinine level, a surrogate of muscle mass, predicts mortality in peritoneal dialysis patients
Nephrol Dial Transplant (2013) 28: 2146 2155 doi: 10.1093/ndt/gft213 Advance Access publication 5 June 2013 Serum creatinine level, a surrogate of muscle mass, predicts mortality in peritoneal dialysis
More informationDialysis Initiation and Optimal Vascular Access: Outcomes and Mortality
Dialysis Initiation and Optimal Vascular Access: Outcomes and Mortality Shannon H. Norris, BSN, RN June 6, 2018 Dialysis Initiation and Optimal Vascular Access: Outcomes and Mortality DISCUSSION: End Stage
More informationChronic Kidney Disease is Associated with Cognitive Decline: the Northern Manhattan Study (NOMAS) Seattle VA Chief of Medicine Rounds June 9, 2009
Chronic Kidney Disease is Associated with Cognitive Decline: the Northern Manhattan Study (NOMAS) Seattle VA Chief of Medicine Rounds June 9, 2009 Minesh Khatri Internal Medicine R2 Background Patients
More informationPredicting and changing the future for people with CKD
Predicting and changing the future for people with CKD I. David Weiner, M.D. Co-holder, C. Craig and Audrae Tisher Chair in Nephrology Professor of Medicine and Physiology and Functional Genomics University
More informationClassification of CKD by Diagnosis
Classification of CKD by Diagnosis Diabetic Kidney Disease Glomerular diseases (autoimmune diseases, systemic infections, drugs, neoplasia) Vascular diseases (renal artery disease, hypertension, microangiopathy)
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Weintraub WS, Grau-Sepulveda MV, Weiss JM, et al. Comparative
More informationTime trends in initiation and dose of dialysis in end-stage renal disease patients in The Netherlands
Nephrol Dial Transplant (2003) 18: 552 558 Original Article Time trends in initiation and dose of dialysis in end-stage renal disease patients in The Netherlands Fabian Termorshuizen 1, Johanna C. Korevaar
More information